New: Introducing the Finviz Crypto Map

Learn More

UBS Shrugs Abbott Laboratories' (ABT) Diagnostic Weakness Affirms 'Buy' Rating

By Neha Gupta | July 31, 2025, 12:23 AM

Abbott Laboratories (NYSE:ABT) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty. On July 21, UBS reiterated a ‘Buy’ rating and a $148 price target on the stock. The bullish stance comes on the heels of the stock coming under pressure following the release of lower fiscal year 2025 sales guidance.

UBS Shrugs Abbott Laboratories' (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating

The biopharmaceutical company is facing weakness in its diagnostic segment. However, the weakness has not altered UBS’s positive stance on the company. That’s because the company is experiencing robust growth, with its MedTech division recording 12.2% organic growth in the second quarter, higher than the consensus estimate of 11.2%.

In addition, UBS is buoyed by Abbott’s 6.9% organic sales growth or 7.5% on excluding COVID diagnostics. The research firm expects robust growth in other segments, including the MedTech pipeline, to offset weakness in the diagnostic segment.

Abbott Laboratories (NYSE:ABT) is a global healthcare company focused on creating life-changing technologies and products that span diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. It is focused on improving health and well-being across all stages of life through innovative solutions and a commitment to accessibility.

While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best 52-Week High Stocks to Buy Now and 10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News

6 hours
21 hours
Jul-30
Jul-29
Jul-29
Jul-29
Jul-29
Jul-29
Jul-28
Jul-28
Jul-28
Jul-27
Jul-25
Jul-25
Jul-25